Wiedemann-steiner syndrome with a de novo mutation in KMT2A: A case report.
Abnormalities, Multiple
/ diagnosis
Asian People
/ genetics
Blepharophimosis
/ diagnosis
Child
Contracture
/ diagnosis
Diagnostic Errors
Facies
Genotype
Growth Disorders
/ diagnosis
Growth Hormone
/ therapeutic use
Heart Defects, Congenital
/ diagnosis
Histone-Lysine N-Methyltransferase
/ genetics
Humans
Hypertrichosis
/ congenital
Intellectual Disability
/ diagnosis
Male
Microcephaly
/ diagnosis
Mutation
Myeloid-Lymphoid Leukemia Protein
/ genetics
Phenotype
Skin Abnormalities
/ diagnosis
Treatment Outcome
Urogenital Abnormalities
/ diagnosis
Exome Sequencing
/ methods
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
Apr 2020
Apr 2020
Historique:
entrez:
22
4
2020
pubmed:
22
4
2020
medline:
24
4
2020
Statut:
ppublish
Résumé
Wiedemann-Steiner syndrome (WDSTS, online mendelian inheritance in man 605130) is a rare autosomal dominant disorder characterized by hypertrichosis cubiti. Here, we report a Chinese boy who do not show the characteristic of hypertrichosis cubiti, and was misdiagnosed as blepharophimosis-ptosis-epicanthus inversus syndrome at first. We found a de novo frameshift mutation (p.Glu390Lysfs*10) in the KMT2A gene, which was not reported before. Our study increases the cohort of Chinese WDSTS patients, and expand the WDSTS phenotypic and variation spectrum. The patient demonstrated typical craniofacial features of blepharophimosis-ptosis-epicanthus inversus syndrome, including small palpebral fissures, ptosis, telecanthus, and epicanthus inversus, besides he had congenital heart disease (ventricular septal defects), strabismus, hypotonia, amblyopia, delayed speech and language development, delayed psychomotor development, and amblyopia (HP:0000646) which was not reported before. FOXL2 gene was cloned and sequenced, however, there was no mutation detected in this patient. The result of Chromosomal microarray analysis was normal. The patient was diagnosed as WDSTS by whole exome sequencing. The patient received cardiac surgery, frontalis suspension and regular speech and occupational therapy. He also treated with growth hormone (GH). The patient's symptoms are improved after cardiac surgery and frontalis suspension, he can express himself well now and had a 10 cm gain in height. As the relationship between genotype and phenotype becomes more and more clear, WES is incredibly powerful tool to diagnose the disease of WDSTS.
Identifiants
pubmed: 32311999
doi: 10.1097/MD.0000000000019813
pii: 00005792-202004170-00083
pmc: PMC7440326
doi:
Substances chimiques
KMT2A protein, human
0
Myeloid-Lymphoid Leukemia Protein
149025-06-9
Growth Hormone
9002-72-6
Histone-Lysine N-Methyltransferase
EC 2.1.1.43
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e19813Références
Am J Med Genet A. 2019 Feb;179(2):300-305
pubmed: 30549396
Clin Genet. 2018 Jul;94(1):141-152
pubmed: 29574747
Am J Med Genet A. 2010 Sep;152A(9):2372-5
pubmed: 20803650
Am J Med Genet A. 2015 Sep;167A(9):2182-7
pubmed: 25929198
Orphanet J Rare Dis. 2018 Oct 11;13(1):178
pubmed: 30305169
Endocrinol Diabetes Metab Case Rep. 2018 Aug 23;2018:
pubmed: 30159147
Am J Med Genet A. 2017 Feb;173(2):510-514
pubmed: 27759909
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Clin Dysmorphol. 2000 Apr;9(2):155-6
pubmed: 10826636
BMC Med Genet. 2015 Sep 01;16:73
pubmed: 26323275
J Med Genet. 1988 Jan;25(1):47-51
pubmed: 3270326
Mol Cell. 2002 Nov;10(5):1107-17
pubmed: 12453418
Am J Med Genet A. 2017 Oct;173(10):2821-2825
pubmed: 28815892
Am J Hum Genet. 2012 Aug 10;91(2):358-64
pubmed: 22795537
Genet Med. 2014 Feb;16(2):176-82
pubmed: 23928913